GLP-1 Weight-Loss Drug Slows Biological Aging Markers in HIV Patients, Study Finds
TL;DR Summary
In a randomized trial of 108 adults with HIV-associated lipohypertrophy, semaglutide slowed several epigenetic aging clocks—9% on DunedinPACE and reduced PCGrimAge–related aging risk—suggesting GLP-1 drugs may influence aging biology beyond weight loss, though larger studies are needed.
- Popular Weight-Loss Drug Found To Slow Biological Aging in Landmark Human Trial SciTechDaily
- Study: Popular GLP-1 Drug May Slow Down Biological Aging UC San Diego Today
- Wegovy and Ozempic seen to slow down biological ageing markers in HIV adults Labmate Online
- Weight-loss drug may slow down signs of aging Earth.com
- Could Ozempic Slow Aging? A New Clinical Trial Analysis Opens The Door StudyFinds
Reading Insights
Total Reads
0
Unique Readers
6
Time Saved
5 min
vs 6 min read
Condensed
97%
1,091 → 37 words
Want the full story? Read the original article
Read on SciTechDaily